Product Recalls in Washington

Product recalls affecting Washington — including food, drugs, consumer products, medical devices, and vehicles distributed to Washington. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,840 recalls have been distributed to Washington in the last 12 months.

51,768 total recalls
2,840 in last 12 months

Showing 24412460 of 13,410 recalls

DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Erythromycin Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCL Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Neomycin and Polymyxin B Sulfates Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: PAREMYD (hydroxyamphetamine hydrobromide/ tropicamide ophthalmic solution)...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Timolol Maleate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears OINTMENT Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Ciprofloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund